MX355572B - Metodo para la preparacion de trigliceridos de acidos grasos de cadena media. - Google Patents
Metodo para la preparacion de trigliceridos de acidos grasos de cadena media.Info
- Publication number
- MX355572B MX355572B MX2014010446A MX2014010446A MX355572B MX 355572 B MX355572 B MX 355572B MX 2014010446 A MX2014010446 A MX 2014010446A MX 2014010446 A MX2014010446 A MX 2014010446A MX 355572 B MX355572 B MX 355572B
- Authority
- MX
- Mexico
- Prior art keywords
- triglycerides
- preparation
- medium
- fatty acids
- chain length
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/02—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
- C11C3/02—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol
- C11C3/025—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with glycerol with a stoechiometric excess of glycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Fats And Perfumes (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe un método para la preparación de ésteres de glicerol (triglicéridos) de ácidos grasos monocarboxílicos de cadena media que consisten en la reacción del precursor del ácido graso libre y glicerol en presencia de un catalizador bajo vacío parcial; el procedimiento utiliza preferentemente un catalizador metálico tal como un óxido o un cloruro de tungsteno, molibdeno, calcio, cinc, cromo o magnesio; el método de la invención permite la preparación con alto rendimiento y pureza alta (>99.5%) del triglicérido final; el método de la presente permite la formación de triglicéridos sin solvente; también se contempla el triglicérido obtenido mediante el método y la composición farmacéutica que contiene el triglicérido como excipiente o como ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261605489P | 2012-03-01 | 2012-03-01 | |
PCT/CA2013/000174 WO2013126990A1 (en) | 2012-03-01 | 2013-02-28 | Method for the preparation of triglycerides of medium-chain length fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014010446A MX2014010446A (es) | 2014-10-13 |
MX355572B true MX355572B (es) | 2018-04-23 |
Family
ID=49081484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014010446A MX355572B (es) | 2012-03-01 | 2013-02-28 | Metodo para la preparacion de trigliceridos de acidos grasos de cadena media. |
Country Status (21)
Country | Link |
---|---|
US (1) | US9447016B2 (es) |
EP (1) | EP2819989B1 (es) |
JP (1) | JP6148690B2 (es) |
KR (1) | KR102098974B1 (es) |
CN (1) | CN104203896B (es) |
AU (1) | AU2013225572B2 (es) |
CA (1) | CA2865664C (es) |
DK (1) | DK2819989T3 (es) |
ES (1) | ES2719077T3 (es) |
HK (1) | HK1205096A1 (es) |
IL (1) | IL234104A (es) |
MX (1) | MX355572B (es) |
NZ (1) | NZ629227A (es) |
PH (1) | PH12014501863A1 (es) |
PL (1) | PL2819989T3 (es) |
PT (1) | PT2819989T (es) |
RU (1) | RU2641307C2 (es) |
TR (1) | TR201905237T4 (es) |
TW (1) | TWI572352B (es) |
WO (1) | WO2013126990A1 (es) |
ZA (1) | ZA201405956B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2016006329A (es) * | 2013-11-14 | 2016-09-06 | Ultragenyx Pharmaceutical Inc | Composiciones solidas de trigliceridos y usos de estas. |
PH12014000195A1 (en) | 2014-07-10 | 2017-01-23 | Lao Dean Jr | Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid |
RU2017114438A (ru) * | 2014-10-10 | 2018-10-26 | Нестек Са | Композиции и способы повышения подвижности или активности или лечения дряхлости |
CN104689327B (zh) * | 2015-03-23 | 2019-02-12 | 山东北大高科华泰制药有限公司 | 谷维素液体组合物 |
WO2017093449A1 (en) * | 2015-12-04 | 2017-06-08 | Nestec S.A. | Medium chain triglyceride compositions |
JP6847514B2 (ja) * | 2017-01-20 | 2021-03-24 | 日清オイリオグループ株式会社 | 固化性又は結晶性トリグリセリド |
CN107129430B (zh) * | 2017-05-09 | 2020-08-21 | 辽宁新兴药业股份有限公司 | 一种原料药中链甘油三酸酯合成方法 |
JP7223744B2 (ja) | 2017-07-26 | 2023-02-16 | ティージーエックス ソフト チュー エルエルシー | 獣医用途のためのデンプン不含のソフトチュー |
KR102043442B1 (ko) * | 2019-02-01 | 2019-11-11 | 주식회사 천강 | 지방산 및 유리지방산을 다량 함유한 유지를 촉매를 사용하지 않고 바이오디젤 원료용 저산가 글리세라이드를 제조하는 방법 |
CN109836328A (zh) * | 2019-03-16 | 2019-06-04 | 广州隽沐生物科技股份有限公司 | 中链甘油三酸酯的合成方法 |
CN110204440A (zh) * | 2019-04-30 | 2019-09-06 | 沈阳化工大学 | 一种乙酰丙酸基液体燃料的制备方法 |
CN110105203A (zh) * | 2019-04-30 | 2019-08-09 | 沈阳化工大学 | 一种乙酰丙酸六碳酯的制备方法 |
FR3112344B1 (fr) | 2020-07-10 | 2022-12-23 | Arkema France | Procédé de préparation d’un triglycéride d’acide heptanoïque |
CN112321422B (zh) * | 2020-10-27 | 2023-04-25 | 湖北葛店人福药用辅料有限责任公司 | 辛酸癸酸单双甘油酯的制备方法 |
KR20240011763A (ko) * | 2021-05-21 | 2024-01-26 | 이오이 올레오 게엠베하 | 고 등급 지방산 폴리올 에스테르, 특히 지방산 글리세롤 에스테르의 제조 방법 |
AU2022375734A1 (en) * | 2021-11-01 | 2024-05-16 | Bioveritas, Llc | Triglycerides and structured lipids from short- and medium-chain fatty acids |
WO2024069590A1 (en) | 2022-09-30 | 2024-04-04 | Amyris Bio Products Portugal, Unipessoal, Ltda. | Compositions and methods for preservation of food and cosmetic products |
CN115536531B (zh) * | 2022-11-02 | 2024-05-28 | 湖北葛店人福药用辅料有限责任公司 | 一种三辛酸甘油酯的制备方法 |
WO2024126775A1 (en) | 2022-12-16 | 2024-06-20 | Itf Research Pharma, S.L.U | Melatonin liquid formulations |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB978085A (en) * | 1961-12-11 | 1964-12-16 | Canada Packers Ltd | Edible oils from tall oil fatty acids |
JPS5145105A (en) * | 1974-10-16 | 1976-04-17 | Nisshin Oil Mills Ltd | Goseiyuno seiseihoho |
JPS6256452A (ja) * | 1985-09-04 | 1987-03-12 | Nippon Oil & Fats Co Ltd | エステルの製造法 |
JPH04145046A (ja) * | 1990-10-03 | 1992-05-19 | New Japan Chem Co Ltd | ポリグリセリン脂肪酸エステルの製造方法 |
US20080009467A1 (en) * | 2000-05-01 | 2008-01-10 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism |
US6835750B1 (en) * | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
NZ541140A (en) * | 2001-04-18 | 2006-11-30 | Prometic Biosciences Inc | Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
DE10130491A1 (de) * | 2001-06-25 | 2003-04-17 | Heirler Horst | Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas |
JP2003135001A (ja) * | 2001-11-02 | 2003-05-13 | Nisshin Oillio Ltd | 食用油脂及びそれを用いた乳化油脂組成物 |
ATE419846T1 (de) * | 2003-02-07 | 2009-01-15 | Prometic Biosciences Inc | Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese |
CN1266107C (zh) * | 2004-07-01 | 2006-07-26 | 江南大学 | 一种中碳链甘三酯的合成和纯化方法 |
FR2884716B1 (fr) * | 2005-04-22 | 2009-08-21 | Thea Sa Lab | Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires |
KR100737742B1 (ko) * | 2005-12-05 | 2007-07-10 | 대화제약 주식회사 | 파클리탁셀 조성물의 제조 방법 |
JP2008174483A (ja) * | 2007-01-18 | 2008-07-31 | Gifu Univ | カルボン酸多価アルコールエステルの製造方法 |
PH12010501172A1 (en) * | 2007-12-19 | 2009-06-25 | Bayer Technology Services Gmbh | Method for producing fatty acid alkyl esters |
CN101381304A (zh) * | 2008-10-22 | 2009-03-11 | 上海化工研究院 | 一种甘油三辛酸酯-羧基-13c3的合成方法 |
-
2013
- 2013-02-27 TW TW102106946A patent/TWI572352B/zh not_active IP Right Cessation
- 2013-02-28 JP JP2014559042A patent/JP6148690B2/ja not_active Expired - Fee Related
- 2013-02-28 DK DK13755282.4T patent/DK2819989T3/en active
- 2013-02-28 PL PL13755282T patent/PL2819989T3/pl unknown
- 2013-02-28 WO PCT/CA2013/000174 patent/WO2013126990A1/en active Application Filing
- 2013-02-28 US US14/382,080 patent/US9447016B2/en active Active
- 2013-02-28 CA CA2865664A patent/CA2865664C/en active Active
- 2013-02-28 CN CN201380011748.5A patent/CN104203896B/zh not_active Expired - Fee Related
- 2013-02-28 NZ NZ629227A patent/NZ629227A/en not_active IP Right Cessation
- 2013-02-28 MX MX2014010446A patent/MX355572B/es active IP Right Grant
- 2013-02-28 ES ES13755282T patent/ES2719077T3/es active Active
- 2013-02-28 PT PT13755282T patent/PT2819989T/pt unknown
- 2013-02-28 RU RU2014139702A patent/RU2641307C2/ru active
- 2013-02-28 AU AU2013225572A patent/AU2013225572B2/en not_active Ceased
- 2013-02-28 TR TR2019/05237T patent/TR201905237T4/tr unknown
- 2013-02-28 KR KR1020147027579A patent/KR102098974B1/ko active IP Right Grant
- 2013-02-28 EP EP13755282.4A patent/EP2819989B1/en active Active
-
2014
- 2014-08-13 IL IL234104A patent/IL234104A/en active IP Right Grant
- 2014-08-14 ZA ZA2014/05956A patent/ZA201405956B/en unknown
- 2014-08-18 PH PH12014501863A patent/PH12014501863A1/en unknown
-
2015
- 2015-06-08 HK HK15105417.7A patent/HK1205096A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX355572B (es) | Metodo para la preparacion de trigliceridos de acidos grasos de cadena media. | |
PH12016500216A1 (en) | Stable pharmaceutical composition and methods of using same | |
WO2017087710A3 (en) | Production of fatty olefin derivatives via olefin metathesis | |
MY153613A (en) | Method for synthesizing an omega-amino acid or ester from a monounsaturated fatty acid or ester | |
MX2015004947A (es) | Sistema cristalino multicomponente que comprende nilotinib y formadores de cocristal seleccionados. | |
WO2010108060A8 (en) | Fatty acid monoglyceride compositions | |
TR201905687T4 (tr) | Travoprost hazırlanışına yönelik proses. | |
MY189907A (en) | Catalyst for production of methacrylic acid, method of producing the same, method of producing methacrylic acid, and method of producing methacrylic acid ester | |
MD20150089A2 (ro) | Formă preparativă farmaceutică conţinând fosfatidilcolină pentru tratarea colitei ulceroase | |
MX2012001922A (es) | Metodo para preparar una forma solida de acido acetico y productos de la misma. | |
WO2013128419A3 (en) | Pharmaceutical compositions comprising boronic acid compounds | |
WO2012112841A3 (en) | [1,2,4]oxadiazol-3-yl acid salts and crystalline forms and their preparation | |
MX2014013761A (es) | Acidos (3r,4r,5s)-5-guanidino-4-acetamido-3-(pentan-3-iloxi)cicloh exen-1-carboxilicos fluorosustituidos, sus esteres y uso de los mismos. | |
MX2017013164A (es) | Un procedimiento para la produccion de acidos o esteres carboxilicos etilenicamente insaturados. | |
MX2014004688A (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. | |
WO2013052971A3 (en) | Process for producing ethanol using hydrogenation catalysts prepared from polyoxometalate precursors | |
FR2970252B1 (fr) | Procede de production de composes nitrile-acide gras | |
MY181680A (en) | Use of sulfonic acid for recovering glycerol resulting from the triglyceride transesterification reaction | |
WO2011107843A3 (en) | Process for the preparation of atazanavir sulfate substantially free of diastereomers | |
CA2928305C (en) | A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof | |
NZ593781A (en) | Polyunsaturated fatty acid and diol ester as an anti-acne agent | |
MX2013012773A (es) | Sustancias farmacologicas, composiciones farmaceuticas y metodos para la preparacion de las mismas. | |
MX2015007885A (es) | Compuestos farmaceuticos. | |
SA112330847B1 (ar) | عملية لتحضير حمض ميثاكريليك وإسترات حمض ميثاكريليك | |
MY177491A (en) | Method for producing monoglyceride-containing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: PROMETIC PHARMA SMT LIMITED |
|
FG | Grant or registration |